Key Metrics
CiteScore 

4.5
Impact Factor 

< 5
SJR 

Q3Pharmacology

SNIP 

0.9
Recommended pre-submission checks
Powered by 

Acta Pharmaceutica Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | SCIENDO |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | EUR 900 |
| Publication Time | 20 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Croatian Pharmaceutical Society |
| Frequency | Quarterly |
| Publication Start Year | 1951 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 20 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Acta Pharmaceutica ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Acta Pharmaceutica
Size exclusion chromatography as a characterization tool for quality control of marine biopharmaceutical keyhole limpet hemocyanin.
- 23 Oct 2026
- Acta pharmaceutica (Zagreb, Croatia)
Nanocarrier based drug delivery for rheumatoid arthritis: Current strategies and future directions.
- 23 Oct 2026
- Acta pharmaceutica (Zagreb, Croatia)
Syringin inhibits insulin resistance through the PI3K/AKT pathway.
- 13 Oct 2026
- Acta pharmaceutica (Zagreb, Croatia)
First-in-class HPLC-fluorescence method for quantification of roscovitine in plasma: Greenness assessment and application to pharmacokinetic studies in rats.
- 13 Oct 2026
- Acta pharmaceutica (Zagreb, Croatia)
Adverse event reporting of golimumab: A disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database.
- 13 Oct 2026
- Acta pharmaceutica (Zagreb, Croatia)
A meta-analysis of the effects of Zingiber officinale on metabolic indices among patients with type 2 diabetes.
- 23 Sep 2026
- Acta pharmaceutica (Zagreb, Croatia)
Size exclusion chromatography as a characterization tool for quality control of marine biopharmaceutical keyhole limpet hemocyanin.
- 23 Oct 2026
- Acta pharmaceutica (Zagreb, Croatia)
Nanocarrier based drug delivery for rheumatoid arthritis: Current strategies and future directions.
- 23 Oct 2026
- Acta pharmaceutica (Zagreb, Croatia)
Syringin inhibits insulin resistance through the PI3K/AKT pathway.
- 13 Oct 2026
- Acta pharmaceutica (Zagreb, Croatia)
First-in-class HPLC-fluorescence method for quantification of roscovitine in plasma: Greenness assessment and application to pharmacokinetic studies in rats.
- 13 Oct 2026
- Acta pharmaceutica (Zagreb, Croatia)
Adverse event reporting of golimumab: A disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database.
- 13 Oct 2026
- Acta pharmaceutica (Zagreb, Croatia)
A meta-analysis of the effects of Zingiber officinale on metabolic indices among patients with type 2 diabetes.
- 23 Sep 2026
- Acta pharmaceutica (Zagreb, Croatia)